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Abstract
Western equine encephalitis virus (WEEV) is a naturally occurring recombinant virus derived from ancestral Sindbis and
Eastern equine encephalitis viruses. We previously showed that infection by WEEV isolates McMillan (McM) and IMP-181
(IMP) results in high (,90–100%) and low (0%) mortality, respectively, in outbred CD-1 mice when virus is delivered by
either subcutaneous or aerosol routes. However, relatively little is known about specific virulence determinants of WEEV. We
previously observed that IMP infected Culex tarsalis mosquitoes at a high rate (app. 80%) following ingestion of an infected
bloodmeal but these mosquitoes were infected by McM at a much lower rate (10%). To understand the viral role in these
phenotypic differences, we characterized the pathogenic phenotypes of McM/IMP chimeras. Chimeras encoding the E2 of
McM on an IMP backbone (or the reciprocal) had the most significant effect on infection phenotypes in mice or mosquitoes.
Furthermore, exchanging the arginine, present on IMP E2 glycoprotein at position 214, for the glutamine present at the
same position on McM, ablated mouse mortality. Curiously, the reciprocal exchange did not confer mouse virulence to the
IMP virus. Mosquito infectivity was also determined and significantly, one of the important loci was the same as the mouse
virulence determinant identified above. Replacing either IMP E2 amino acid 181 or 214 with the corresponding McM amino
acid lowered mosquito infection rates to McM-like levels. As with the mouse neurovirulence, reciprocal exchange of amino
acids did not confer mosquito infectivity. The identification of WEEV E2 amino acid 214 as necessary for both IMP mosquito
infectivity and McM mouse virulence indicates that they are mutually exclusive phenotypes and suggests an explanation for
the lack of human or equine WEE cases even in the presence of active transmission.
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Introduction
Western equine encephalitis virus (WEEV) is an alphavirus
endemic to and enzootic in North America. The virus, first
isolated in 1930 by inoculation of brain material from a sick horse
into a healthy one [1], is maintained in the zoonotic cycle which
involves transmission from (primarily) Culex (Cx.) tarsalis mosquitoes
to passerine birds [2]. The range of the virus principally
corresponds to the geographic distribution of the mosquito vector.
Periodically, humans or equines exposed to the virus via Cx. tarsalis
or other bridge vectors have resulted in large epidemics or
epizootics of encephalitis. The first equine outbreaks recorded in
the 1930’s affected several hundred thousand equines with
mortality rates of up to 50% [1,3]. At least 10 states in the US
and 5 Canadian provinces had human and/or equine outbreaks
during the 1930’s–1950’s. While human epidemics were not as
severe as equine epizootics, the case fatality was still high ranging
from 8 – 15% [3,4]. Outbreaks continued to occur in the western
parts of Canada and the US through the 1970’s but the magnitude
of these episodes was decreasing over time. The last documented
human case of WEE in the US occurred in 1999 when a single
patient in Minnesota was diagnosed with the disease [5]. Canada
has seen a similar decline in WEEV presence with little or no
activity detected since the 1990’s.
The disappearance of WEEV disease in humans and equids
suggested that WEEV had become extinct. However, the periodic
isolation of the virus from mosquitoes during non-epidemic
periods combined with the detection of seropositive animals in
surveillance programs indicated that the virus is indeed still present
in zoonotic cycles [3,6]. Several studies using multiple North
American WEEV isolates failed identify a general temporal
decline in mammalian, avian, host vector, or in vitro virulence
since the mid-1900’s peak in mammalian cases [7–9]. Our
previous work examined the virulence of several distinct strains of
WEEV and demonstrated significant differences in both viremia
and mortality in an outbred mouse model [10]. In contrast to
earlier studies, among the specific isolates tested, virulence did
appear to decline with time. In agreement with previous outbred
mouse studies [11], the earliest isolate we examined, McMillan
(McM), originally isolated from a human case in 1941, was lethal
to CD-1 mice by 4 days post-infection (dpi) in a dose independent
manner. This is in contrast to the most recent isolate in that study,
IMP-181 (IMP; isolated in 2005 from mosquito pools), which
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induced no mortality in the same animal model system [10]. Based
on those results, we hypothesized that there exists a viral genetic
explanation for the differing levels of disease activity in that model.
To understand the role of specific viral determinants that decrease
virulence and to identify viral genetic regions or mutations
responsible for this phenotypic variation, we developed a series of
McM/IMP chimeric viruses and point mutants that would
precisely locate which, if any, viral genetic elements regulated
virulence in an animal model. Additionally, we used this same
panel of viruses in Cx. tarsalis to evaluate the ability of various viral
genetic elements to modulate infection or dissemination within the
vector. Our results identify specific amino acids which impart




BHK-21 (BHK; baby hamster kidney), C6/36 (Aedes albopictus),
DF-1 (chick), and Vero E6 cells were obtained from American
Type Culture Collection (Manassas, VA) or from the CDC cell
culture reference section. The Neuro-2a (N2a) murine neuroblas-
toma cell line was a gift from Dr. Mark Zabel (Colorado State
University) and was originally obtained from ATCC (catalog
#CCL-131). All cells were propagated in minimal essential
medium with 10% heat-inactivated fetal calf serum at 37uC (28
uC for C6/36) in a 7% CO2 incubator.
Virus strains
WEEV McM, originally isolated in 1941 from the brain of an
infected human, isolate was obtained from the Arbovirus
Reference Collection at the Centers for Disease Control and
Prevention, Fort Collins, Colorado, USA. The WEEV McM
infectious clone was constructed by Dr. Thomas Welte, CSU.
WEEV IMP was isolated from a Cx. tarsalis in 2005 in Imperial
County, CA. The WEEV IMP infectious clone was constructed by
Dr. Michael Anishchenko and obtained from Dr. Aaron Brault
(CDC, Ft. Collins, CO). Passage history prior to cloning was as
follows: WEEV McM-MP2, SMB1, V2; WEEV IMP-V2 (MP,
mouse; SMB, suckling mouse brain; V, Vero cells) (Logue 2009).
Seed stocks for these experiments were made by electroporation of
viral RNA from infectious clones into BHK cells grown in minimal
essential medium with 10% fetal calf serum. Cell culture
supernatant was collected when 90% of cells showed cytopathic
effect (48–72 hrs) and stored in aliquots supplemented with 20%
FBS at 280uC. Virus titer was determined by plaque assay on
Vero cells as previously described [10].
Chimeric virus construction
Where possible, chimeric viruses were constructed using the
existing conserved, unique restrictions sites, KpnI and AvrII,
present at WEEV McM nucleotides 7576 and 9682, respectively.
Construction of the chimeras receiving material not bordered by
these sites and the point chimeras was based on a strategy using
type IIs restriction enzymes adapted from Blakqori and Weber
[12] and is outlined in detail by Saxton-Shaw et al for the
generation chikungunya/o9nyong nyong chimeric viruses [13].
This method allowed the generation of chimeras and point
mutants without the introduction of nonnative nucleotides to the
virus.
In general, cloning was completed in a three step process. First,
an amplicon was generated by PCR from the parental backbone
virus clone extending from the AvrII or KpnI site toward the other
(inward). The PCR primers would add a site for convenient
cloning into the pUC19 polycloning site. To the other end of the
amplicon, a SapI recognition site oriented inward was added so
that the restriction site was the exact sequence at which the change
was to occur, the chimera junction. A second restriction site was
added outside the SapI site for cloning into pUC19. This amplicon
was cloned into a modified pUC19 plasmid that previously had the
BsmBI sites and SapI site removed. A second PCR amplicon was
generated from the clone donating the fragment from the AvrII or
KpnI site to the chimera junction. Outside the AvrII or KpnI site,
this amplicon contained the same convenient recognition site as
was added outside the SapI site in the previous amplicon. On the
opposite terminus was added a SapI site oriented inward such that
restriction would occur at the same site as on the first amplicon,
leaving complementary overhangs. Digestion of both the previous
plasmid and the second amplicon with SapI and the terminal
convenient restriction site and subsequent ligation generated a
plasmid cassette containing a chimeric AvrII-KpnI region.
Digestion of this plasmid and the parental virus clone with AvrII
and KpnI and subsequent ligation resulted in a full-length
chimeric WEEV clone free of artifactual base changes introduced
by the cloning process.
Generation of pair 5, which exchanges a region not bordered by
AvrII or KpnI, required an additional step. Generation of the first
cloning plasmid was performed with an amplicon that contained a
linker enzyme site (MfeI) between the added SapI site and selected
pUC19 cloning site. The second amplicon was generated from the
same parent and also contained a pUC19 cloning enzyme site
outside AvrII or KpnI and an MfeI site outside the SapI site. This
amplicon was cloned into the first plasmid using a second pUC19
cloning enzyme site and MfeI, generating a -SapI-MfeI-SapI-
motif at the point of foreign DNA insertion. The DNA to be
inserted was amplified from the other parental clone, adding SapI
sites to both termini, oriented inward such that the restriction sites
were situated over the desired cloning junction. Digestion of this
amplicon and plasmid with SapI and ligation created a cloning
cassette containing the chimeric region from the AvrII to KpnI
sites that were then inserted back into the parental clone as above.
Finally, the point mutants were generated by a three-step
process. The region of interest, including the site to be mutated
and flanking sequence to include convenient, ideally unique,
cloning sites, was broken into two PCR fragments. Each PCR
fragment was comprised of the sequence from the mutation site
through the cloning site. The PCR primers contained SapI
recognition sites oriented inward toward the mutation site and cut
sites modified to leave complementary overhangs containing the
desired base change. Digestion of the PCR amplicons with SapI
and the relevant enzymes to restrict the opposite ends followed by
a three-part ligation with a modified pUC19 plasmid yielded a
plasmid construct containing the region of interest with the desired
base change. Once the change was confirmed by sequence
analysis, the region was digested and removed from the
provisionary plasmid construct and inserted into the full-length
WEEV plasmid. Full-length plasmid constructs were confirmed to
have incorporated the desired change by sequence analysis.
Virus growth curves
T-25 flasks or 24-well plates (Corning, Corning, NY) were
seeded with BHK, N2a, C6/36, or DF-1 cells. When approxi-
mately 90% confluent, cell monolayers were infected with virus at
low multiplicity (MOI = 0.01–0.05). At specified times, superna-
tant was removed from three wells or two flasks for each virus on
each cell type and placed in a screw-cap cryovial at 270uC until
titration by plaque assay. Titration results for each virus were
compared at all time points by the two tailed t-test.
Viral Determinants of WEE Virus Infection
PLOS ONE | www.plosone.org 2 March 2013 | Volume 8 | Issue 3 | e60427
Chick infection studies
The use of chickens was reviewed and approved by the Animal
Care and Use Committee at Colorado State University (protocol
#12-3418A). Care and handling of chicks was in accordance with
the PHS Policy and Guide for the Care and Use of Laboratory
Animals. Three day old chicks (n = 6/virus) were infected with 104
plaque-forming units (pfu) of McM and IMP viruses by
subcutaneous injection and monitored daily by a veterinarian for
7 days. Chicks were bled at days 1, 2, 3, and 4 dpi to determine
viremia. The humane endpoint for these experiments was at the
termination of the experiment (7 dpi).
Mouse virulence studies
The use of all mice was reviewed and approved by the Animal
Care and Use Committee at Colorado State University (Protocol
#11-2605A). Five week-old female CD-1 mice (The Jackson
Laboratory, Bar Harbor, ME or Charles River Labs, Wilmington,
MA) were allowed to acclimate for 7–10 days. Viral stocks were
diluted in serum-free MEM to a concentration of 26104 pfu per
mL. Mice were infected in groups of 5–10, at least two replications
per virus (final n = 10–15), by subcutaneous (s.c.) injection inside
the left thigh with 103 pfu in 50 mL. Inocula were titered by plaque
assay on Vero cells to confirm dosage.
All infected and uninfected control mice were visually moni-
tored by laboratory personnel at a minimum of two times daily.
Additionally, mice were monitored once daily by Laboratory
Animal Resources and results of these observations reported to the
University Veterinarian. Our protocols allow continuation until
clinical signs are evident. Mice exhibiting lethargy, unresponsive-
ness, or neurological signs (postural instability, seizures, piloerec-
tion, and/or paralysis) were euthanized by CO2 inhalation. The
day a mouse was euthanized was considered the day of death for
calculation of mean time to death (MTD). Survivorship was
followed for a period of 14 days and compared among virus
constructs by Fisher’s exact test.
Mosquito infections
Three to four day-old adult Cx. tarsalis mosquitoes were fed on a
blood meal containing WEEV. The blood meal contained equal
parts of virus, FBS with 10% sucrose, and goose blood (Colorado
Serum CO., Boulder, CO) washed with phosphate-buffered saline
and packed by centrifugation. A Hemotek feeding system
(Discovery Workshops, Accrington, Lancashire, UK) was used to
deliver the blood meal to the mosquitoes at 37uC. The mosquitoes
were allowed to feed for 1 hour on the apparatus. The fully
engorged females were separated and placed into a humidified
environmental chamber (Thermo Scientific 3960, Houston, TX)
and held at 28uC for 8 days until processing. Blood meal titers
were determined by plaque assay and ranged from 2.06105–
2.06106 pfu/mL.
After the 8 day holding period, mosquitoes were cold
anesthetized and decapitated, placing the bodies into 1.7 ml tubes
(Eppendorf, Hauppauge, NY). A 400 ml aliquot of Dulbecco’s
minimal essential medium (DMEM) (Gibco, Carlsbad, CA)
supplemented with 10% fetal bovine serum (FBS), 100 U/ml of
penicillin and streptomycin, 1 U/ml of fungizone and gentamycin
was placed into each tube and the sample was homogenized using
a pestle (Kontes, Vineland, NJ). The supernatant was clarified by
filtration through a 0.2 mM syringe filter (Pall, Ann Arbor, MI)
into a clean tube and placed at 270uC until use.
Virus presence was determined by pipetting 100 mL of clarified
supernatant onto Vero cells in a 96-well plate. The plate was
incubated at 37uC under 5% CO2 and monitored daily for
cytopathic effect (CPE). Samples were considered virus positive if
CPE was observed.
Results
WEEV McM E2 amino acid 214 is necessary for mouse
virulence
A panel of McM/IMP chimeras was constructed to identify the
determinants of WEEV McM virulence in CD-1 mice (figure 1).
Rescued virus was administered by subcutaneous inoculation of 6
week-old CD-1 mice. Chimera pair 1 containing exchanges in the
E1 gene region retained phenotypes similar to the parental viruses
with 86% mortality and 0% mortality for the McM-based and
IMP-based chimeras, respectively. Exchange of the region from
the unique AvrII restriction site at McM nt 7576 to the unique
KpnI site at McM nt 9552 (pair 2; figure 1) did transfer the
virulent phenotype with the McM-based chimera losing virulence
and the IMP-based chimera becoming virulent (80%) but with a
relatively delayed mean time to death of 7.9 days. These results
suggested that virulence is determined by capsid, E3, and/or E2
genes.
Chimera pair 3 and 4 exchanged the capsid gene from the AvrII
site to the 39 end and the E2 gene from the 59 terminus to the
KpnI site (figure 1). Exchanging the capsid gene did not confer or
remove the virulent phenotype. The IMP and McM-based
chimeras exhibited 0% and 80% mortality in CD-1 mice,
respectively. However, exchanging the E2 gene did have an effect
on virulence. The McM-based chimera containing the IMP E2
gene completely lost its virulence while the IMP-based chimera
with the McM E2 gene exhibited 40% mortality (MTD = 7.7
days). The E2 gene was further manipulated by exchanging E2 nts
1–518 or E2 nts 519–1226. Pair 5, exchanging E2 nts 1–518
retained the phenotype of the parental viruses, though mortality
was further decreased for the McM-based chimera (30%). Placing
the IMP-derived E2 nts 519–1226 in the McM backbone reduced
mortality to 0% (pair 6, figure 1). The reciprocal chimera also
exhibited reduced mortality (10%). Therefore the minimal
necessary determinant essential for mouse virulence was narrowed
to a region of McM E2 from nt 519 to the KpnI site at 1226.
Alignment of the IMP and McM E2 sequences (accession
numbers GQ287641 and GQ287640, respectively) revealed 19
nucleotide differences between the strains in this region. Of these,
11 were silent and eight led to seven amino acid differences (two
nucleotide changes are involved in a single amino acid change;
figure 2). Fourteen point mutants were constructed representing
the reciprocal chimeras for each of the seven loci. Exchanges at six
of the seven loci (aa 181, 217, 224, 231, 277, and 390) retained the
parental neurovirulence phenotype in the mouse. Mortality rates
associated with the McM-based point mutants ranged from 70–
100% (table 1). Despite retaining a generally virulent phenotype,
placement of the IMP-like amino acid at positions 181 and 224
yielded significantly less mortality than the McM parent (p,0.05).
Mortality among IMP-based mutants ranged from 0–10%, none
significantly different than the IMP parent. Only the exchange of
amino acid 214 (Q to R) affected the pathogenic phenotype.
Mortality following infection with the IMP-based virus containing
the McM E2 Q214 (IMP E2 R214Q) residue remained at the
previously observed 0%. The reciprocal chimera [McM-based
mutant containing IMP-like E2 R214 (McM E2 Q214R)] showed
significant loss of virulence relative to the McM parent virus as
only a single animal succumbed to disease (n = 10; p,0.001)
indicating that while not sufficient to confer virulence in an
otherwise attenuated backbone, the McM E2 amino acid 214 is
necessary for virulence in our mouse model of WEEV infection.
Viral Determinants of WEE Virus Infection
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The single animal that succumbed following infection with the
McM E2 Q214R appeared to follow an atypical disease course
(hind limb paralysis only) that will be examined in future studies.
That animal and the single mouse that succumbed to infection
with IMP E2 S390A are the only examples in these studies of
infection with a virus containing arginine at E2 aa 214 resulting in
a lethal outcome.
Baby chicken infection results with structural chimeras
and E2 point mutations
As avians are the natural reservoirs for WEEV, we further
sought to examine the characteristics of these viruses in a readily
available avian model. 104 pfu of McM, IMP, McM E2 Q214R
and IMP E2 R214Q viruses were subcutaneously injected into 3
day old chicks to observe any differences among the viruses in their
resulting viremia within an avian model. Viremia in chicks was
detected for McM at 1 dpi but no viremia was detected at days 2–
3 dpi (figure 3). Viremia was detected at 1–3 dpi in chicks infected
Figure 1. Cx. tarsalis infectivity and murine virulence of WEEV McM, IMP, and several chimeric viruses (gray = WEEV McM-derived
fragments; black = WEEV IMP-derived fragments). Chimeric viruses were rescued from cells electroporated with infectious clones. Mosquito
infectivity was determined by the presence of replication competent virus in the body 8 days after giving an infectious bloodmeal. Mice were
infected by subcutaneous injection of 103 pfu in 50 uL inoculum inside the right thigh. Mice were followed for 14 days after infection for signs of
neurological disease. Unique, conserved restriction sites used for chimera clone construction along with their position within the WEEV McM genome
are noted.
doi:10.1371/journal.pone.0060427.g001
Figure 2. Amino acid alignment of WEEV McM and WEEV IMP E2 protein (accession numbers GQ287640 and GQ287641,
respectively). The region shaded in gray is 39 of the unique KpnI restriction site and not included in exchanges using this site. The mid-E2 cloning
junction used in pairs 5 and 6 is denoted by the black bar (E2 nt 517, aa 173). The seven amino acid differences in the E2 region exchanged by pair 6
are circled.
doi:10.1371/journal.pone.0060427.g002
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with IMP or IMP E2 R214Q virus. Though none of the viremia
differences reached statistical significance, the highest measurable
viremias occurred on day two (figure 3) and were associated with
IMP or IMP E2 R214Q viruses. In the present study, none of the
infected chicks showed signs of disease during the 7 dpi
monitoring period. Hardy et al showed 1 day old chicks were
highly susceptible to WEEV-induced disease [14]. It is not clear if
the different results are due to an age-dependent susceptibility to
WEEV disease or some other detail of our model. However, that
viremia was more often associated with IMP infection suggests that
the observed McM virulence in mice is not due to an
extraordinary general virulence in vertebrates. Additional studies
in avian hosts, including passerine birds, are proposed for the
future.
Mosquito infection results with structural chimeras and
E2 point mutations
In addition to the mouse virulence phenotype, we used McM/
IMP chimeras to investigate the determinants of the observed
difference in mosquito infectivity. Cx. tarsalis mosquitoes were
allowed to feed on blood meals containing each of the 12 structural
chimeras and 14 E2 point mutation exchanges (figure 1, table 1).
The infectivity of the parent strains was 10.0% and 78.9% for
McM and IMP, respectively. Clone pairs 1 and 3 yielded no
significant change from the original parent infection phenotype;
however pair 2 restored the infection phenotype and suggested a
determinant in the capsid, E3, or E2 regions. 87.9% of Cx. tarsalis
given McM backbone virus were infected and 30% of mosquitoes
given IMP backbone virus were infected. Clone pairs 4, 5, and 6
further identified the determinant of infection as residing in the
same region of E2 (nts 519–1226) that determined mouse
virulence. Pair 6 had a demonstrated infectivity of 23.8% for
both rescued viruses, representing a deviation from the parental
infection phenotype.
Infectivity for the point mutations at E2 amino acids 181 and
214 were 5.1% and 11.7%, respectively, for the IMP strain
mutants and 13.3% and 0% for the McM mutants, representing a
significant reduction of the IMP parental mosquito infection
phenotype (p,0.001 for both IMP-based viruses), but not
restoration (Table 1). The remaining pairs resulted in a slight
reduction and an approximately 3-fold increase in infectivity for
the IMP and McM-based chimeras, respectively (the pairs
exchanging amino acid 224 and 231 will all significantly different
than the parent viruses, p,0.05). These results suggest that while
there may be multiple determinants, the IMP arginine at E2
position 214 is critical but not sufficient for mosquito infectivity.
Multi-step growth curves of McM, IMP, and E2 aa 214
point chimeras
To determine whether the observed phenotypes were due to
general replicative differences, multi-step growth curves of McM,
IMP, or the McM or IMP-based E2 aa 214 point chimeras were
performed in both mammalian and insect cells. In BHK cells, all
four viruses grew similarly well, rapidly increasing in titer from 10–
100 pfu/mL to 106–107 pfu/mL (figure 4A). No consistent
statistical differences were observed among the four viruses,
though the titer of McM E2 Q214R was significantly greater than
McM, IMP, and IMP E2 R214Q 72 hpi (p,0.05).
N2a murine neuroblastoma cells were used to determine
whether growth differences among viruses might account for the
observed differences in mouse mortality due to neuron infection.
Again, no overt growth difference was observed among, McM,
IMP, McM E2 Q214R, and IMP E2 R214Q viruses through
72 hpi (figure 4B). Though at 72 hpi, IMP trended toward having
lower virus titers than McM, at both 48 and 72 hpi, no statistically
significant difference in virus titer was observed between any of the
four viruses.
Cultured DF-1 chicken embryo fibroblast cells were infected
with McM, IMP, McM E2 Q214R, and IMP E2 R214Q viruses
to observe any growth differences that would be regulated by the
virus-vertebrate reservoir dynamics. In this cell line, significant
growth differences were observed, especially through 24 hpi
(figure 4C). All 4 viruses were different at 18 hpi, with the McM
and McM E2 Q214R McM viruses 1–2.5 logs higher than IMP
and IMP E2 R214Q viruses at 24 hpi. Peak viral titers were
significantly different between McM (24 hpi) and IMP (36 hpi),
but no other viruses. The titers for the point mutants were
significantly higher than the parent viruses at 48 and 72 hpi.
In C6/36 mosquito cells, all four viruses showed similar
replication kinetics with no statistically significant differences
observed (figure 4D). Mean titer measurements at 72 hpi ranged
from 6.8 Log10 pfu/mL for IMP (E2-R214Q) to 7.5 Log10 pfu/
mL for McM.
Discussion
Extensive pathogenic studies have been performed on several
alphaviruses strains and the availability of infectious clones for
many alphaviruses has allowed reverse genetics studies to identify
the molecular basis of various phenotypes, including vertebrate
virulence and vector adaptation. In different models nsP2, nsP3,
capsid, E1, and E2 were all identified as pathogenic determinants
[2,15–17].
In this study, we identified minimal infection and virulence
determinants of two distinct WEEV phenotypes. A single amino
acid, E2 Q214, was identified as necessary for WEEV McM-
mediated pathogenesis in a murine model of infection. Impor-
tantly, the same amino acid position, E2 R214, was identified as
necessary for efficient WEEV IMP-mediated infectivity of the
primary mosquito vector, Cx. tarsalis. That these two phenotypes
Table 1. Mosquito infectivity in Cx. tarsalis and mouse




D % mosquito Infection (n)% mouse mortality (MTD)*
McM 181 K-E 13.3 (30) 70 (6.7)
IMP 181 E-K 5.1 (32) 0
McM 214 Q-R 0(34) 10 (5)
IMP 214 R-Q 11.7(70) 0
McM 217 M-I 20.0 (30) 90 (4.4)
IMP 217 I-M 68.4 (19) 0
McM 224 R-K 37.1 (35) 80 (5.0)
IMP 224 K-R 72.4 (29) 0
McM 231 L-S 29.4 (34) 90 (4.6)
IMP 231 S-L 41.9(31) 0
McM 277 T-M 35.3(34) 100 (4.3)
IMP 277 M-T 54.5(33) 0
McM 390 A-S 29.6(27) 100 (4.5)
IMP 390 S-A 61.5(33) 10 (12.0)
*MTD = mean time to death in days post-infection.
doi:10.1371/journal.pone.0060427.t001
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are determined by different amino acids at the same position
suggests that lethality and transmission are mutually exclusive in
this model, suggesting an explanation as to why there are so few
mammalian cases in the presence of active transmission. Although
IMP E2 R214Q virus had viremic profiles similar to IMP virus
infected chicks, the R to Q change significantly affected mosquito
infectivity. Curiously, in neither case did the reciprocal point
chimera confer the examined phenotype to the previously
incompetent parental virus. Such a transfer of increased virulence
phenotype likely requires multiple loci, a notion supported by the
variable mouse mortality among the chimeric viruses in this study.
Our in vitro studies conclude that the recombinant viruses used
in this report do not have defects in replication as indicated by the
growth curve analysis in multiple cell lines. In general, McM
showed the most rapid replication kinetics compared to all other
viruses. However, in vitro results did not correlate well with in vivo
findings. Mouse virulence or mosquito infectivity of each virus,
including the single point mutants, did not correlate with any
differences in growth kinetics in vitro. These findings underscore
the limitations of in vitro assays in predicting virulence in a mouse
model of infection or infectivity of the primary vector mosquito
species. In vitro studies remain necessary, however, to demonstrate
that recombinant viruses are not overtly compromised with respect
to replication kinetics.
Among alphaviruses, relatively little is known about WEEV
structure and pathogenesis. Much must be extrapolated from
studies of other alphaviruses, including Sindbis virus (SINV). The
region of the SINV E2 glycoprotein from approximately amino
acid 172 through 220 has been implicated in cell recognition
[18,19] and roughly corresponds to E2 domain B, a disordered
domain from amino acid 167 through 254 [20]. Cryo-electron
microscopic (cryo-EM) reconstruction of SINV E1-E2 complexes
suggests that E2 amino acid 214 is located on the extreme tip of
the E2 spike and within domain B [20,21] supporting a direct role
for E2 amino acid 214 in cell recognition or receptor binding. The
exchange of a polar neutral glutamine for a positively charged
arginine, and vice-versa, at position 214 could be expected to
significantly alter such molecular interactions. Similarly, E2 amino
acid 181, also involved in vector infectivity is likely located in
domain B near the tip of E2. The amino acid switch at this
position is more significant, exchanging positively charged lysine
and negatively charged glutamic acid. This major change could
affect interactions with cellular recognition molecules directly or
indirectly by altering the conformation of the E2 spike tip.
Previous studies examining SINV vector adaptation have
primarily implicated residues located in domain A. Pierro et al.
found E2 amino acids 55, 70, 95, 96, and 116–118 to be involved
in enhanced SINV infectivity of Aedes (Ae.) aegypti [22,23]. While
the mechanism is likely different based on the location within the
protein, amino acids 55 and 70 present a situation analogous to
the current report. SINV E2 Q55H/E70K results in increased
virulence in suckling mice and increased binding to neuronal cells
[24,25]. Viruses containing the reciprocal mutations, E2 H55Q/
K70E demonstrate increased infectivity for Ae. aegypti [22].
Chikungunya E2 amino acid 211 and Venezuelan equine
encephalitis virus E2 amino acids 207, 213, and 218 were
implicated in adaptation to their respective vectors [26–28]. X-ray
crystallographic and cryo-EM structures also place these amino
acids at or near the tip of the E2 spike [29,30].
Nagata et al. previously examined the molecular determinants
of WEEV pathogenesis in mice [31]. That study differed from the
current study in several ways: 7–20 week old BALB/c mice were
used, mice were inoculated by the intranasal route, and all isolates
used were 100% lethal to mice in this model. The authors showed
by correlating structural protein phylogenetic analysis and
virulence that the three most virulent strains clustered together
and the five least virulent strains clustered together with sequence
divergence apparently correlating with changing virulence. Inter-
Figure 3. Viremia in 3-day-old chickens following subcutaneous challenge. Absence of bar indicates for all determinations viremia was
below the limit of detection (0.82 log10 pfu/mL).
doi:10.1371/journal.pone.0060427.g003
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estingly, two of the three most virulent strains contain E2 Q214.
One of these two strains is McM and the other California, a strain
phylogenetically closely related to McM. The remaining strains,
including Fleming, the most virulent strain used in that study,
contain IMP-like E2 R214. That five different uniformly lethal
strains contain E2 R214 is not surprising. Given that our data
suggest the presence of multiple loci responsible for pathogenesis,
it is possible that other differences between these five strains and
the McM/California genotype compensate for R214 to render
them pathogenic to mice that is not present in IMP or McM.
Additional studies will be required to address this possibility.
In summary, we have used our previously defined mouse model
of WEEV pathogenesis to determine that different amino acids at
the same position within the E2 glycoprotein are necessary for
both WEEV McM mouse virulence and WEEV IMP vector
infectivity. WEEV IMP may have an advantage in the transmis-
sion cycle by efficiently infecting the avian host and producing
high vector competence in the Cx. tarsalis strain. Our studies
indicate that increased virulence in CD-1 mice is accompanied by
decreased mosquito infectivity, suggesting a plausible explanation
for the current lack of epidemic WEEV.
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